Top Big Cap Negative News Movers Premarket: ADBE: -4% Earnings SMR: -3.5% Downgraded to SELL @ UBS EXEL: -3% FDA Extended Review Period for
Top Big Cap Negative News Movers Premarket: ADBE: -4% Earnings SMR: -3.5% Downgraded to SELL @ UBS EXEL: -3% FDA Extended Review Period for Colorectal Cancer Drug